BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 38778266)

  • 21. Human Papillomavirus infection and cervical lesions in HIV infected women on antiretroviral treatment in Thailand.
    Delory T; Ngo-Giang-Huong N; Rangdaeng S; Chotivanich N; Limtrakul A; Putiyanun C; Suriyachai P; Matanasarawut W; Jarupanich T; Liampongsabuddhi P; Heard I; Jourdain G; Lallemant M; Le Coeur S;
    J Infect; 2017 May; 74(5):501-511. PubMed ID: 28254419
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence and genotype distribution of human papillomavirus in women living with HIV/AIDS in an area of Northeast Brazil.
    da Silva BEB; Santos VS; Santos IER; Araújo ED; Alves MV; Silva LADS; de Aragão Batista MV; de Lemos LMD
    J Med Virol; 2020 Dec; 92(12):3279-3287. PubMed ID: 32330294
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The burden, distribution and risk factors for cervical oncogenic human papilloma virus infection in HIV positive Nigerian women.
    Ezechi OC; Ostergren PO; Nwaokorie FO; Ujah IA; Odberg Pettersson K
    Virol J; 2014 Jan; 11():5. PubMed ID: 24433568
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cervico-vaginal self-collection in HIV-infected and uninfected women from Tapajós region, Amazon, Brazil: High acceptability, hrHPV diversity and risk factors.
    Rodrigues LLS; Morgado MG; Sahasrabuddhe VV; De Paula VS; Oliveira NS; Chavez-Juan E; Da Silva DM; Kast WM; Nicol AF; Pilotto JH
    Gynecol Oncol; 2018 Oct; 151(1):102-110. PubMed ID: 30087059
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High-risk human papillomavirus genotype distribution and attribution to cervical cancer and precancerous lesions in a rural Chinese population.
    Zhao XL; Hu SY; Zhang Q; Dong L; Feng RM; Han R; Zhao FH
    J Gynecol Oncol; 2017 Jul; 28(4):e30. PubMed ID: 28541628
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High-risk human papillomavirus distribution according to human immunodeficiency virus status among women with cervical cancer in Abidjan, Côte d'Ivoire, 2018 to 2020.
    Boni SP; Tenet V; Horo A; Heideman DAM; Bleeker MCG; Tanon A; Mian B; Mohenou ID; Ekouevi DK; Gheit T; Didi-Kouko Coulibaly J; Tchounga BK; Adoubi I; Clifford GM; Jaquet A;
    Int J Cancer; 2024 Mar; 154(6):962-968. PubMed ID: 37942579
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human papillomavirus in oropharyngeal squamous cell carcinoma in South-Eastern Norway: prevalence, genotype, and survival.
    Fossum GH; Lie AK; Jebsen P; Sandlie LE; Mork J
    Eur Arch Otorhinolaryngol; 2017 Nov; 274(11):4003-4010. PubMed ID: 28933005
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The diversity of human papillomavirus infection among human immunodeficiency virus-infected women in Yunnan, China.
    Zhang HY; Fei MD; Jiang Y; Fei QY; Qian H; Xu L; Jin YN; Jiang CQ; Li HX; Tiggelaar SM; Smith JS; Sahasrabuddhe VV; Qiao YL
    Virol J; 2014 Dec; 11():202. PubMed ID: 25481842
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Genotype distribution and behavioral risk factor analysis of human papillomavirus infection among Kazak women in Xinjiang Uygur Autonomous Region].
    Wang Y; Dong X; Zhao XL; Rezhake R; Shen GQ; Talehati D; Liu LP; Zhao FH
    Zhonghua Liu Xing Bing Xue Za Zhi; 2020 Dec; 41(12):2112-2118. PubMed ID: 33378825
    [No Abstract]   [Full Text] [Related]  

  • 30. Epidemiology of cervical human papillomavirus (HPV) infection and squamous intraepithelial lesions (SIL) among a cohort of HIV-infected and uninfected Ghanaian women.
    Obiri-Yeboah D; Akakpo PK; Mutocheluh M; Adjei-Danso E; Allornuvor G; Amoako-Sakyi D; Adu-Sarkodie Y; Mayaud P
    BMC Cancer; 2017 Oct; 17(1):688. PubMed ID: 29037188
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence and distribution of high-risk human papillomavirus genotypes in invasive carcinoma of the uterine cervix in Uruguay.
    Berois N; De Cremoux P; Mazal D; Sica A; Cedeira M; Caserta B; Barrios E; Osinaga E; Sastre-Garau X
    Int J Gynecol Cancer; 2013 Mar; 23(3):527-32. PubMed ID: 23392403
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence and risk factors associated with high-risk human papillomavirus infection among women living with HIV (WLWH) at a tertiary health facility in Accra, Ghana.
    Agyare Gyane F; Modey E; Maya E; Bonney EY; Abaidoo-Myles A; Paintsil E; Torpey K
    PLoS One; 2024; 19(5):e0303535. PubMed ID: 38814956
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of Multiplex Polymerase Chain Reaction for Detection of High-Risk Human Papillomavirus Genotypes in Women Attending Routine Cervical Cancer Screening in Harare.
    Marembo T; Dube Mandishora R; Borok M
    Intervirology; 2019; 62(2):90-95. PubMed ID: 31412350
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High prevalence and incidence of HPV-related anal cancer precursor lesions in HIV-positive women in the late HAART era.
    Hidalgo-Tenorio C; de Jesus SE; Esquivias J; Pasquau J
    Enferm Infecc Microbiol Clin (Engl Ed); 2018 Nov; 36(9):555-562. PubMed ID: 29208455
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Incidence and clearance of anal high-risk human papillomavirus in HIV-positive men who have sex with men: estimates and risk factors.
    Geskus RB; González C; Torres M; Del Romero J; Viciana P; Masiá M; Blanco JR; Iribarren M; De Sanjosé S; Hernández-Novoa B; Ortiz M; Del Amo J;
    AIDS; 2016 Jan; 30(1):37-44. PubMed ID: 26355673
    [TBL] [Abstract][Full Text] [Related]  

  • 36. What drives the number of high-risk human papillomavirus types in the anal canal in HIV-positive men who have sex with men?
    del Amo J; González C; Geskus RB; Torres M; Del Romero J; Viciana P; Masiá M; Blanco JR; Hernández-Novoa B; Ortiz M;
    J Infect Dis; 2013 Apr; 207(8):1235-41. PubMed ID: 23325914
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of HIV-1 and/or HIV-2 infection and CD4 count on cervical HPV DNA detection in women from Senegal, West Africa.
    Hanisch RA; Sow PS; Toure M; Dem A; Dembele B; Toure P; Winer RL; Hughes JP; Gottlieb GS; Feng Q; Kiviat NB; Hawes SE;
    J Clin Virol; 2013 Dec; 58(4):696-702. PubMed ID: 24210330
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Re-valuation of annual cytology using HPV self-sampling to upgrade prevention (REACH UP): A feasibility study in women living with HIV in the UK.
    Cicconi P; Wells C; McCarthy B; Wareing S; Andersson MI; Fox J; Lwanga J; Pal N; Burns F; Woodward C; Malek R; Sabin CA; Dorrell L
    HIV Med; 2022 Apr; 23(4):390-396. PubMed ID: 35243750
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence and genotype-specific distribution of human papillomavirus in Burundi according to HIV status and urban or rural residence and its implications for control.
    Ndizeye Z; Vanden Broeck D; Lebelo RL; Bogers J; Benoy I; Van Geertruyden JP
    PLoS One; 2019; 14(6):e0209303. PubMed ID: 31237894
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Population-based study on the prevalence of and risk factors for human papillomavirus infection in Qujing of Yunnan province, Southwest China.
    Sun LL; Jin Q; Li H; Zhou XR; Song ZQ; Cheng XM; Tao T; Liang B; Xu L; Wang YR; Zhen Y; He JW; Shen K
    Virol J; 2012 Aug; 9():153. PubMed ID: 22873487
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.